Literature DB >> 31718289

Sugar ligand-mediated drug delivery.

Fang Chen1, Gangliang Huang1, Hualiang Huang2.   

Abstract

Sugar ligand molecules, such as mannose, galactose and glucose, can bind to drug-delivery systems, making them targeted. These glycosylation ligands have the advantages of nontoxicity, no immunogenicity, good biocompatibility and biodegradation. They can be widely used in glycosylation-modified drug-delivery systems. Herein, the targeting mechanisms, synthesis methods and targeting characteristics of glycosylation-modified drug-delivery systems were reviewed.

Entities:  

Keywords:  applications; drug delivery; glycosylation ligands; targeting mechanisms

Year:  2019        PMID: 31718289     DOI: 10.4155/fmc-2019-0114

Source DB:  PubMed          Journal:  Future Med Chem        ISSN: 1756-8919            Impact factor:   3.808


  6 in total

1.  Bioinformatics analysis of structures and ligand-bindings of predicted zymogen granule protein observed on Bali cattle (Bos javanicus) saliva.

Authors:  Djoko Kisworo; Sulaiman Ngongu Depamede
Journal:  J Adv Vet Anim Res       Date:  2021-06-18

Review 2.  Bioactive potential of natural biomaterials: identification, retention and assessment of biological properties.

Authors:  Kieran Joyce; Georgina Targa Fabra; Yagmur Bozkurt; Abhay Pandit
Journal:  Signal Transduct Target Ther       Date:  2021-03-19

3.  Galactomannan-Decorated Lipidic Nanocarrier for Gene Supplementation Therapy in Fabry Disease.

Authors:  Julen Rodríguez-Castejón; Itziar Gómez-Aguado; Marina Beraza-Millor; María Ángeles Solinís; Ana Del Pozo-Rodríguez; Alicia Rodríguez-Gascón
Journal:  Nanomaterials (Basel)       Date:  2022-07-08       Impact factor: 5.719

4.  Mannose-decorated ginsenoside Rb1 albumin nanoparticles for targeted anti-inflammatory therapy.

Authors:  Zhihui Fu; Xiaohui Wang; Xuan Lu; Ying Yang; Lingling Zhao; Lin Zhou; Kaikai Wang; Hanlin Fu
Journal:  Front Bioeng Biotechnol       Date:  2022-08-15

5.  α-Galactosidase A Augmentation by Non-Viral Gene Therapy: Evaluation in Fabry Disease Mice.

Authors:  Julen Rodríguez-Castejón; Ana Alarcia-Lacalle; Itziar Gómez-Aguado; Mónica Vicente-Pascual; María Ángeles Solinís Aspiazu; Ana Del Pozo-Rodríguez; Alicia Rodríguez-Gascón
Journal:  Pharmaceutics       Date:  2021-05-21       Impact factor: 6.321

Review 6.  Bio-Nanocarriers for Lung Cancer Management: Befriending the Barriers.

Authors:  Shruti Rawal; Mayur Patel
Journal:  Nanomicro Lett       Date:  2021-06-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.